MARIZYME, INC. — Revenue by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3b8e84a4-170c-449d-aff0-b481a7afcbf4/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $645.8k | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-018935 |
| FY 2022 | $233.5k | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-008914 |
| FY 2021 | $210.3k | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-008531 |
| FY 2020 | $197.1k | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-008936 |
| FY 2019 | $0 | 2019-01-01 – 2019-12-31 | evidence 0001078782-20-000251 |
| FY 2018 | $20.2k | 2018-01-01 – 2018-12-31 | evidence 0001078782-19-000201 |
| FY 2017 | $101.2k | 2017-01-01 – 2017-12-31 | evidence 0001078782-18-000652 |
| FY 2016 | $291.1k | 2016-01-01 – 2016-12-31 | evidence 0001078782-18-000652 |
| FY 2015 | $407.7k | 2015-01-01 – 2015-12-31 | evidence 0001078782-18-000652 |
| FY 2014 | $0 | 2014-01-01 – 2014-12-31 | evidence 0001078782-18-000652 |
| FY 2013 | $0 | 2013-01-01 – 2013-12-31 | evidence 0001078782-18-000652 |
| FY 2012 | $45.0k | 2012-01-01 – 2012-12-31 | evidence 0001078782-18-000652 |
| FY 2011 | $31.9M | 2011-04-01 – 2012-03-31 | evidence 0001144204-12-051266 |
| FY 2010 | $27.7M | 2010-04-01 – 2011-03-31 | evidence 0001144204-12-039664 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).